Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site
about
sameAs
Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cellsSignaling by target of rapamycin proteins in cell growth controlMutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylationDisruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell developmentSpatial regulation of the mTORC1 system in amino acids sensing pathwayAutophagy is essential to support skeletal muscle plasticity in response to endurance exerciseReceptor internalization in yeast requires the Tor2-Rho1 signaling pathway.Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networksRoles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalizationMechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylationThe mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase CTOR signaling.Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.Mis-regulation of mammalian target of rapamycin (mTOR) complexes induced by albuminuria in proximal tubules.Intracellular calcium and calmodulin link brain-derived neurotrophic factor to p70S6 kinase phosphorylation and dendritic protein synthesis.Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing.S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer.The complexes of mammalian target of rapamycin.Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels.mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.Nutritionally-induced catch-up growthFrontier of epilepsy research - mTOR signaling pathway.Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferationRalA functions as an indispensable signal mediator for the nutrient-sensing systemThe role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.Modulation of mTOR Activity by μ-Opioid Receptor is Dependent upon the Association of Receptor and FK506-Binding Protein 12The Role of Laser Speckle Imaging in Port-Wine Stain Research: Recent Advances and Opportunities.RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells.The amino acid sensitive TOR pathway from yeast to mammals.P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus.A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyDual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.mTOR pathway and Ca²⁺ stores mobilization in aged smooth muscle cellsRegulation of a third conserved phosphorylation site in SGK1Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma.Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs
P2860
Q21245715-01BFF2E6-70C3-453E-9EBE-B653C7F5BF91Q24522447-E50F6E96-43B3-493C-B618-0A79061439DBQ24530079-1AC09482-14BA-4FC3-AC37-E57CFAB37EF5Q24535576-E04ECEBF-93C9-481C-B099-E168028A2CE8Q24563399-FD3EFF46-96D4-40C9-892F-7D4E7F5ECD07Q24612853-7E1FA9EF-534C-430A-958D-575380AD95C8Q27000625-2B5C1559-9E01-4849-8F77-BF8385080601Q27934242-D80D1FB9-CE9F-4EF7-994E-966D14E49ACAQ28255399-32BB9570-6308-4F7F-A13B-531DF2BDE992Q28396707-0639303A-4C7B-47C1-8996-949655142F37Q28568275-5F825D8B-AB9F-4075-95E3-B523F0DCB68FQ28587901-EB7CBF75-9C8B-49EF-B65A-9931B858D9AEQ30312086-C0EE5B7F-5DD6-45B2-B13D-2626E7F28CDDQ33706349-8F873086-05B0-4411-8A4E-A0F677985875Q33761197-F74E78C1-E2AE-49CE-83C8-DFF84B7AE0ADQ33802613-73CEDCDF-BAF9-4A55-B8D8-8282D4419C98Q33903835-B58C6E0D-410D-442F-A824-F673F3C114B5Q33961949-E8306123-A895-406A-B535-56395D750886Q34116818-690E3F39-FFDC-4E42-9323-0C6B84077659Q34501488-2894DB22-9922-4568-8F89-398E8C2B9ECFQ34542438-89753386-9212-4521-9B60-4DC7A22002C5Q34666165-8ADEFE48-8E31-4FC7-966C-1493943C4953Q35003838-2CE15CC9-3E8A-4DCC-92A7-DBB0231F1C06Q35014198-7D8E17BD-9678-46A8-9D7E-081A7C07F2C8Q35571394-5B19F0A1-0E84-4784-B5F9-1A035975F593Q35676903-0A59F871-711F-4BCC-846C-AE2F29BCC695Q35688212-9FFA1D60-7AEA-4621-8F73-49442C8FF075Q35769311-649728FF-D41A-4267-8E96-E83D18DFC634Q35970012-F51F5FC5-AB65-4F5F-932B-2BF8ED29A51BQ36169696-479C863C-1260-4061-B623-C2C2D21C1D70Q36463349-624B7BE2-07AF-422E-B9CC-F1761FAD0BABQ36473396-5038B329-A3AD-45BD-816A-553C03774755Q36807172-A5DF58D4-E4BE-48EF-8A78-DD38C8DA61A7Q36836915-F8D2998A-4661-4E4F-9372-9E71E8904866Q36941194-24FAAD1E-E687-4C40-8495-9C6E1867D6AEQ36981483-B870EA50-434F-4D62-9A39-ACE740FDBA60Q37081895-08080CD1-4979-4949-9966-7C4625F5F85FQ37554503-F6EA023E-78AF-469A-87AE-C620D026F059Q37582441-16BDECD8-8102-4298-8BF4-5002D0BAAE9AQ37745377-B82CF19D-2E79-4162-A161-6096B7A1FFCB
P2860
Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Regulation of an activated S6 ...... rapamycin phosphorylation site
@ast
Regulation of an activated S6 ...... rapamycin phosphorylation site
@en
Regulation of an activated S6 ...... rapamycin phosphorylation site
@nl
type
label
Regulation of an activated S6 ...... rapamycin phosphorylation site
@ast
Regulation of an activated S6 ...... rapamycin phosphorylation site
@en
Regulation of an activated S6 ...... rapamycin phosphorylation site
@nl
prefLabel
Regulation of an activated S6 ...... rapamycin phosphorylation site
@ast
Regulation of an activated S6 ...... rapamycin phosphorylation site
@en
Regulation of an activated S6 ...... rapamycin phosphorylation site
@nl
P2093
P2860
P356
P1476
Regulation of an activated S6 ...... rapamycin phosphorylation site
@en
P2093
George Thomas
Masao Saitoh
Nicholas Pullen
Patrick B Dennis
P2860
P304
P356
10.1074/JBC.M201745200
P407
P577
2002-05-31T00:00:00Z